TrialJournal of cancer research and clinical oncology2022

Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial.

Osman Öcal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.